The direct and indirect costs of axial spondyloarthritis (axSpA) in Singapore.
Elenore Judy B UyShi Yun KwohJie Kie PhangMcvin Hua Heng CheenKa Keat LimCharmaine Tze May WangYing Ying LeungHwee-Ling KohTruls OstbyeJulian ThumbooWeng Seng Warren FongPublished in: International journal of rheumatic diseases (2020)
The disease burden of axSpA in Singapore is not trivial given that the disease is relatively common. This highlights the need for measures to accommodate patients with axSpA economically in Singapore.
Keyphrases